Subject(s)
Diaphragm/cytology , Idiopathic Pulmonary Fibrosis/physiopathology , Idiopathic Pulmonary Fibrosis/therapy , Neuromuscular Blockade/mortality , Respiration, Artificial/adverse effects , Respiration, Artificial/methods , Ventilator-Induced Lung Injury/etiology , Aged , Female , Humans , Male , Middle AgedABSTRACT
BACKGROUND: Exacerbation of idiopathic interstitial pneumonias (IIPs) requiring mechanical ventilation is associated with high mortality. However, evidence for the optimal management strategy in patients on mechanical ventilation for exacerbation of IIPs is scarce. This study aimed to evaluate the association between continuous rocuronium infusion and in-hospital mortality in patients with exacerbation of IIPs requiring mechanical ventilation. METHODS: The effect of continuous rocuronium infusion was retrospectively analyzed using data in the Japanese Diagnosis Procedure Combination in-patient database from July 2010 to March 2016. We compared 28-d mortality between the continuous rocuronium infusion group (intravenous doses of ≥ 150 mg/d) and the control group using 1:4 propensity score matching. RESULTS: We enrolled 4,925 subjects. Propensity score matching yielded 66 subjects in the rocuronium group and 264 subjects in the control group. There was no significant difference in 28-d mortality (rocuronium vs control, 52% vs 44%, P = .31) or in-hospital mortality (68% vs 61%, P = .28) between the 2 groups. CONCLUSIONS: Continuous rocuronium infusion was not significantly associated with decreased mortality in patients with exacerbation of IIPs requiring mechanical ventilation.
Subject(s)
Idiopathic Interstitial Pneumonias/mortality , Neuromuscular Blockade/mortality , Neuromuscular Nondepolarizing Agents/administration & dosage , Respiration, Artificial/mortality , Rocuronium/administration & dosage , Aged , Disease Progression , Female , Hospital Mortality , Humans , Idiopathic Interstitial Pneumonias/therapy , Male , Middle Aged , Propensity Score , Respiration, Artificial/methods , Retrospective StudiesABSTRACT
AIM OF THE STUDY: Current guidelines recommend targeted temperature management to improve neurological outcome after cardiac arrest. Evidence regarding an ideal sedative/analgesic regimen including skeletal muscle paralysis is limited. METHODS: Patients were randomized to either a continuous administration of rocuronium (continuous-NMB-group) or to a continuous administration of saline supplemented by rocuronium bolus administration if demanded (bolus-NMB-group). The primary outcome was the number of shivering episodes. Secondary outcomes included survival and neurological status one year after cardiac arrest, time to awakening, length of stay as well as required cumulative dose of rocuronium, midazolam and fentanyl. RESULTS: Sixty-three patients (32 continuous-NMB-group; 31 bolus-NMB-group) were enrolled. Differences in baseline characteristics were not significant. Shivering episodes were detected in 94% of the patients in the bolus-NMB-group compared to 25% of the patients receiving continuous rocuronium infusion (p<0.01). The continuous-NMB-group received significant lower doses of midazolam (4.3±0.8mg/kg vs. 5.1±0.9mg/kg, p<0.01) and fentanyl (62±14µg/kg vs. 71±7µg/kg, p<0.01), but higher cumulative doses of rocuronium (7.8±1.8mg/kg vs. 2.3±1.6mg/kg, p<0.01). Earlier awakening (2 [IQR 2;3] vs. 4 [IQR 2;7.5] days, p=0.04) and decreased length of stay at the ICU (6 [IQR 3;5.9] vs. 10 [IQR 5;15] days, p=0.03) were observed in the continuous-NMB-group. There were no significant differences in survival and quality of life 12 months after cardiac arrest. CONCLUSIONS: Continuous neuromuscular blockade during the first day after resuscitation reduced shivering, midazolam and fentanyl requirement, time to awakening and discharge from intensive care unit. There were no differences in overall survival, cooling rate and time to target temperature.
Subject(s)
Androstanols/administration & dosage , Hypothermia, Induced/methods , Neuromuscular Blockade/methods , Neuromuscular Nondepolarizing Agents/administration & dosage , Out-of-Hospital Cardiac Arrest/therapy , Shivering/drug effects , Aged , Cardiopulmonary Resuscitation , Double-Blind Method , Female , Humans , Hypothermia, Induced/adverse effects , Length of Stay/statistics & numerical data , Male , Middle Aged , Neuromuscular Blockade/adverse effects , Neuromuscular Blockade/mortality , Out-of-Hospital Cardiac Arrest/mortality , RocuroniumABSTRACT
Cuando se comparan las consecuencias de los accidentes anestésicos reclamados que constan en la base de datos del ASA CCP (Closed Claims Project), es significativo señalar que hubo un alto porcentaje de lesiones temporarias o no incapacitantes en los casos de anestesia regional (64 por ciento vs 46 por ciento p<0,05). Entre las lesiones incapacitantes permanentes derivadas de injurias del sistema nervioso periférico se hallan manifestaciones como la paraplejía y la cuadriplejía. Catorce de las reclamaciones legales asociadas con la paraplejía se debieron a síndromes de la anestesia espinal anterior. Los daños neurológicos permanentes fueron la causa más común de los daños incapacitantes, el más frecuente de los cuales (23 por ciento) fue asociado a bloqueos nerviosos para anestesia ocular (13 retrobulbares, 3 peribulbares) en los que hubo pérdida de la visión del ojo afectado. De todas maneras, se debe señalar que las complicaciones neurológicas como manifestaciones secundarias a la utilización de anestésicos locales para anestesia regional son muy poco frecuentes (0,02 y 0,07 por ciento de los casos), aunque es bastante común observar la aparición de manifestaciones neurológicas transitorias (entre 0,01 y 0,8 por ciento). La parestesia y el dolor durante la inyección son señales peligrosas ya que anuncian la posibilidad de la complicación. Se han descripto también abscesos peridurales y meningitis, en especial cuando se realizan bloqueos centrales con catéteres de pequeño diámetro a fin de alcanzar analgesia central para el dolor crónico. En la base de datos de la Mutual de Médicos Anestesiólogos de Buenos Aires están registradas las demandas realizadas contra anestesiólogos y los casos en los cuales los médicos, enfrentados a un incidente crítico, notifican la situación en previsión de una eventual demanda. Al igual que en el estudio de la ASACCP, desconocemos el número total de anestesia realizadas por los colegas adheridos. Hasta el 2004 hubo 339 notificaciones que incluyen 74 demandas, 24 causas penales y 50 causas civiles; 124 casos correspondieron a la anestesia regional, mientras que 215 formaron el grupo de pacientes que recibieron anestesia general. En 8 de los pacientes que presentaron radiculopatías se realizó una anestesia subaracnoidea con bupivacaína al 0,5 por ciento en solución hiperbara, habiéndose inyectado 15 mg (3 ml) de la solución anestésica...(AU)
